We are specializing in the development, integration and commercialization of Life Science technologies, with emphasis on the fields of personalized medicine and cancer research. GHP focuses on new technologies that can be developed and commercialized within a period of three to four years. This is the period in which GHP brings the technology to the optimal stage that produces a significant return on the investment made by the investors.